Palette Life Sciences

company

About

Palette Life Sciences provides a wide range of products to improve the quality of life for the patients it serves.

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$30M
Industries
Health Care,Life Science,Therapeutics
Founded date
Jan 1, 2018
Operating Status
Active

Palette Life Sciences is a fully integrated life sciences company. Palette Life Sciences’ products improve patient outcomes in urology and urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures. The company’s portfolio of available products includes Deflux®, Barrigel®, Solesta®, and Lidbree™. Palette Life Sciences moves rapidly to leverage novel applications of existing technologies to create breakthrough medical solutions. This focus enables the company to serve those often overlooked by traditional medical companies and improve patient quality of life.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$70M
Palette Life Sciences has raised a total of $70M in funding over 2 rounds. Their latest funding was raised on Oct 28, 2021 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 28, 2021 Debt Financing $40M 1 Silicon Valley Bank UK Detail
Oct 20, 2021 Series Unknown $30M 1 Melker Schörling Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Palette Life Sciences is funded by 2 investors. Silicon Valley Bank UK and Melker Schörling are the most recent investors.
Investor Name Lead Investor Funding Round
Silicon Valley Bank UK Yes Debt Financing
Melker Schörling Yes Series Unknown